| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 10, 2026 | ABL Diagnostics strengthens its patent portfolio and viral safety expertise with TEXCELL | A new strategic dimension in virology and bacteriology to enhance the safety of biological products and samples WOIPPY, FRANCE, September 10, 2026 /EINPresswire.com/ -- ABL Diagnostics (Euronext Paris - ISIN: FR001400AHX6), a specialist in ... |
| Jul 17, 2026 | ABL Diagnostics Expands Its Tuberculosis NGS Portfolio to Targeted and Whole Genome Sequencing | Completing ABL Diagnostics' infectious disease portfolio by extending its proven DeepChek® and UltraGene expertise to comprehensive tuberculosis genomics WOIPPY, FRANCE, July 17, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “A... |
| Jul 16, 2026 | ABL Diagnostics Confirms BSI Partnership for IVDR Transition and Long-Term Availability of its CE-IVD Medical Devices | Expanded GRC and R&D capabilities plus an enhanced QMS accelerate IVDR-compliant innovation and prepare for FDA QMSR and global markets. WOIPPY, FRANCE, July 16, 2026 /EINPresswire.com/ -- ABL Diagnostics (Euronext Paris – ISIN: FR00140... |
| Jul 15, 2026 | ABL Diagnostics accélère sa stratégie de santé numérique avec l'achèvement d'un premier jalon majeur de MyNadis | Dix ans après l'acquisition de Fedialis Medica, ABL Diagnostics progresse dans le développement de son système numérique pour le suivi des parcours de soins WOIPPY, FRANCE, July 15, 2026 /EINPresswire.com/ -- ABL Diagnostics (Euronext Paris... |
| Jun 15, 2026 | ABL Diagnostics Announces Renewal of U.S. Patent (US 8,859,198 B2) for Hepatitis B Genotyping and Antiviral Resistance | Reinforcing long-term IP strength in molecular diagnostics and supporting global laboratory partners WOIPPY, FRANCE, June 15, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular diagnostics, bioinfo... |
| Jun 10, 2026 | ABL Diagnostics Showcases Scientific Progress at EMHH 2026, Supporting Strategic Positioning in Molecular Technologies | WOIPPY, FRANCE, June 10, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular technologies, bioinformatics and decision-support solutions for infectious diseases, announces the presentation of three ... |
| Jun 9, 2026 | ABL Diagnostics Advances Platform-Agnostic NGS Strategy Through DeepChek® Verification on Element Biosciences’ AVITI™ | Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in infectious disease sequencing workflows. WOIPPY, FRANCE, June 9, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “A... |
| Jun 8, 2026 | ABL Diagnostics Deepens Laboratory Footprint with Launch of HybridChek for HIV and Tuberculosis Whole Genome Sequencing | By Offering Amplicon and Hybrid Capture on a Single Bioinformatics platform, the Company Expands Capabilities to Cover All Pathogen Sequencing Needs. WOIPPY, FRANCE, June 8, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”)... |
| May 28, 2026 | ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026 | DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for monitoring immunocompromised patient cohorts. WOIPPY, FRANCE, May 28, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 ... |
| May 27, 2026 | ABL Diagnostics Secures New Global Tenders and Continues to Expand Distribution Network | ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions across EMEA, Asia, and the US. WOIPPY, FRANCE, May 27, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”... |
| May 26, 2026 | ABL Diagnostics et le CHRU Nancy : premier bilan positif pour le projet PREDAVIR après 6 mois | WOIPPY, FRANCE, May 26, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”) et le CHRU Nancy annoncent le succès des six premiers mois du projet PREDAVIR (PREvenir le DAnger VIRal), soutenu par le FEDER Grand Est. Les avancée... |
| May 20, 2026 | ABL Diagnostics renforce son leadership mondial dans le génotypage VIH avec DeepChek® Whole Genome HIV | Une nouvelle publication valide la technologie DeepChek® et confirme la position de leader d’ABL Diagnostics dans le génotypage VIH et les solutions NGS WOIPPY, FRANCE, May 20, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABL... |
| May 20, 2026 | ABL Diagnostics Unveils Next-Generation HIV Genotyping Innovation with the Industry’s Broadest Portfolio | International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, reinforcing ABL’s leadership in HIV genomics. WOIPPY, FRANCE, May 20, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR00140... |
| May 18, 2026 | ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security | WOIPPY, FRANCE, May 18, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular diagnostics, bioinformatics and infectious disease solutions, today announces its strategic commitment to integrating Arti... |
| May 12, 2026 | ABL Diagnostics annonce le développement d’un nouveau panel syndromique intégrant la détection du hantavirus par PCR | WOIPPY, FRANCE, May 12, 2026 /EINPresswire.com/ -- ABL Diagnostics (ABLD) annonce le développement d’un nouveau panel syndromique de diagnostic moléculaire intégrant la détection du hantavirus par technologie de PCR en temps réel, afin de r... |
| Apr 13, 2026 | ABL Diagnostics Announces Two New Scientific Publications, Reinforcing its Expertise in HIV Sequencing-based Genotyping | WOIPPY, FRANCE, April 13, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, announces the presentation of two new scientific studies at leading int... |
| Dec 19, 2025 | Advanced Biological Laboratories Signs Non-Binding LOI for Proposed Reverse Merger with ProPhase Labs | ABL SA (Luxembourg)
Prophase Labs
Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company.
PROPHASE LABS (NASDAQ:PRPH)
ABL will gain enhanced a... |
| Oct 30, 2025 | ABL Diagnostics Expands Collaboration with Université Grenoble Alpes and CHU Grenoble for Advanced HCV Testing | Delivering a Robust and Comprehensive HCV Genotyping and Resistance Testing Solution WOIPPY, FRANCE, October 30, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnost... |
| Oct 22, 2025 | ABL Luxembourg Announces Second Strategic Agreement with Alumni Capital to Support ABL Diagnostics’ Growth | ABL SA (Luxembourg)
Alumni Capita
ABL Diagnostics SA (EPA:ABLD)
This renewed collaboration with Alumni Capital demonstrates their confidence in ABL Diagnostics and its innovative solutions. Increasing the float will improve market dynamics”... |
| Oct 21, 2025 | ABL Diagnostics Expands Global Footprint with Additional Exclusive Distribution Partnerships in Cyprus and Montenegro | WOIPPY, FRANCE, October 21, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the appointment of two additional exclusive distribution ... |
| Sep 8, 2025 | ABL Diagnostics partners with Eurobio Scientific UK to expand DeepChek® genotyping in UK & Ireland | WOIPPY, FRANCE, September 8, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the signature of an exclusive distribution agreement wit... |
| Aug 6, 2025 | ABL Announces a Share Purchase Agreement with Alumni Capital to Support the Business Development of ABL Diagnostics | ABL SA (Luxembourg)
Alumni Capital LP LUXEMBOURG VILLE, LUXEMBOURG, August 6, 2025 /EINPresswire.com/ -- Advanced Biological Laboratories (ABL), a diagnostics company, headquartered in Luxembourg, today announced that it has entered into a ... |
| Jul 29, 2025 | ABL Diagnostics to Become Exclusive Distributor of VELADX in EMEA for Molecular Diagnostics | WOIPPY, FRANCE, July 29, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the signing of an exclusive distribution agreement with VELA... |
| Jul 16, 2025 | ABL Diagnostics Signs Distribution Agreement with Anatech to Expand Molecular Detection in South Africa, Southern Africa | WOIPPY, FRANCE, July 16, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce a distribution agreement with Anatech Instruments (Pty) Ltd ... |
| May 21, 2025 | ABL Diagnostics Successfully Verifies DeepChek® Assays & Software on Illumina’s MiSeq™ i100 & MiSeqDx Platforms | WOIPPY, FRANCE, May 21, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is proud to announce the successful verification of its DeepChek® Assays and Softwar... |
| May 7, 2025 | ABL Diagnostics to Increase Net Accounting Income Fivefold by 2024 | ABL Diagnostics SA
A positive and increasing net accounting income in 2024, confirming ABL Diagnostics' ability to consolidate its historical activity
ABL Diagnostics SA (EPA:ABLD)
ABL Diagnostics' net accounting income stood at €285K at De... |
| Apr 2, 2025 | ABL Diagnostics Signs Exclusive Distribution Agreement with Genient to Expand Microbiology Genotyping in India | WOIPPY, FRANCE, April 2, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Privat... |
| Mar 17, 2025 | ABL Diagnostics Signs Exclusive Distribution Agreement with Riken Genesis to Expand Microbiology Genotyping in Japan | WOIPPY, FRANCE, March 17, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Riken Genesis Co.,... |
| Sep 23, 2024 | AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S. | NEWBURYPORT, MA, UNITED STATES, September 23, 2024 /EINPresswire.com/ -- AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular bi... |
| Aug 21, 2024 | ABL Diagnostics continues its surveillance of SARS-CoV-2 variants and prepares for any resurgence of COVID-19 outbreaks | WOIPPY, FRANCE, August 21, 2024 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories today announced its Deep... |
| Jun 10, 2024 | ABL Diagnostics Deeply Involved to Support Fight Against RSV Infection | WOIPPY, FRANCE, June 10, 2024 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the... |
| May 22, 2024 | ABL Diagnostics Showcases Clinical Genotyping Scientific Communications at the European Meeting on HIV and Hepatitis | WOIPPY, FRANCE, May 22, 2024 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is participating to the Eur... |
